12 Comments

I'm going to make myself a big strong coffee and read that again. Admitedly, I got a little lost halfway. I understand, and agree with the point you are making absolutely, but the math will need a second read. Thanks Riggery

Expand full comment

Data, and especially data from the government-Pharma consortium, is the grease being applied to the tracks they've built on the slippery slope of corporate fascism.

Thankfully, some of us saw the sign along the way that read,

"Danger - Bridge Out Ahead",

and jumped off before the edge of the ravine.

Thank you for showing your work.

Expand full comment

What if the limbo period isn't the "Devil's Two Weeks" but actually extends for years? What if you define survivorship bias as not merely surviving, but having the same health you would have had without vax? (Counterfactuals, therefore difficult to prove.) What if the vax makes everything worse than it otherwise would have been for all those that have taken it? It wouldn't be the first drug to do that.

Expand full comment

I'll come back to this one as well. Have 80 emails from Substack this morning so need to go through them quickly to sort the chaff from the grain.

Expand full comment

OK, now I have to go and ask my (mathematician) husband to translate this whole post. Actually, I'm hoping we'll both learn something! Thanks for this.

Expand full comment

The RKI, in Germany, is using (separate dealing with boosters aside):

eps(g) = 1 - P(d,v,s) / P(d,u) = 1 - mu

eps(g) - eps(c) = lambda

eps(0) - eps(g) = mu * lambda / (1+lambda)

So this is always between the c and the o. Unfortunately, they never publish any limbo figures so it is not possible to evaluate those other measures.

Expand full comment
Feb 12, 2022·edited Feb 12, 2022

Love it. Now consider what happens to the crude rates over time as recovered become less susceptible to both infection and severe outcome. They are all still in the denominator somewhere but without knowing the distribution you can get considerable distortion of crude rates; not a big deal with 1% of the population previously infected; huge deal with 25+% of the population previously infected. If the distribution of the previously infected is not equal to the distribution of the vaccine, you results will skew. Not a very reliable metric 2 years in to a pandemic.

AND! if they are distributed proportionately, incidence rates should go down over time, all else being equal because they are dividing the incident rates by the entire cohort(s) even though many of them are no longer vulnerable to severe outcomes (or infection at all prior to Omicron)

Expand full comment

Thank you for explaining the math. I had to read it a couple times, but it explains why the official efficacy being proffered by "#Foulci aka, the science" has made no since.

I'm not Will Hunting, but I am a calibrated bullshit detector and the reported efficacy has never correlated with the facts on the ground.

Expand full comment

A, "jiggery-pokery" :-) Are you a fan of Astrid Lindgren?

Have you seen Fenton/Niel's paper along similar lines? They conclude that the UK data is "anomalous". https://probabilityandlaw.blogspot.com/2022/02/update-bmj-rejects-without-review-paper.html

Expand full comment

A hugely misleading result is what they want and have always wanted.

Expand full comment
Comment removed
Expand full comment